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Infective Endocarditis
Blake Splawinski RN, BSN, CCRN
Otterbein University, Westerville, Ohio
What Is Infective
Endocarditis?
According to Cobo Molinos (2018),
“Infectious endocarditis (IE) is a
disease caused by a microbial
infection of the cardiac
endothelium. The vegetation, with
involvement of the heart valves and
endocardium, are characteristic” (p.
1) IE generally develops in patients
with a previous injury of the cardiac
endothelium. IE is a rare disease
that is difficult to identify and
diagnose, which requires the
collaborative efforts of different
specialist such as intensive care
specialists, infectious disease
specialists, microbiologists,
cardiologists, and surgery specialists
(Cobo Molinos, 2018). IE can also
present in patients with no history
of heart disease due to the ability of
the bacteria to come from different
sources such as oral, wound, or
surgical to name a few (Baddour et
al., 2015). According to Cobo
Molinos (2018), “the following four
IE categories should be separated
according to the location of the
infection and the presence or
absence of intracardiac foreign
material: IE on left native valve ,IE
on left prosthetic valve, right IE, and
related IE with the devices. In
relation to the type of acquisition of
the disease, the following situations
can be identified: IE acquired in the
community, IE associated with
healthcare (nosocomial and nonnosocomial), and IE in injecting drug
addicts” (p. 2). With the multitude
of categories and causes IE is a
difficult illness to diagnose, treat,
and prevent.

Introduction
I have selected IE because I currently work in the Cardiac Thoracic Intensive
Care Unit (CTCU) and we have frequent open-heart surgery patients that develop
infective endocarditis for different reasons ranging from poor oral hygiene to
unsanitary use of intravenous drugs. The pathophysiology behind the infection as
well as the multitude of issues that occur has always interested me. As I continue
my career in nurse anesthesia I will have to perform sedation for these patients that
require surgery as a treatment option and understanding the pathologic process
behind their infection and potential heart valve failure will be beneficial.

Signs and Symptoms
•
•
•
•
•
•

Consistent history and classic oslerian manifestations: sustained bacteremia or
fungemia, evidence of active valvulitis, peripheral emboli, and immunological
vascular phenomena (Baddour et al., 2015).
Septic emboli including digital gangrene and pulmonary emboli (Holland et al.,
2016).
Mycotic aneurysms (Holland et al., 2016)
Petechiae, splinter hemorrhage, intracranial bleeding, and conjunctival
hemorrhage (Cobo Molinos, 2018).
Osler’s nodes can be present which are painful raised lesions on pads of
fingers and toes (Holland et al., 2016).
Cough, fever, and chest pain can present in patients with IE (Baddour et al.,
2015)

Pathophysiological Processes of Infective
Endocarditis
Pathogens can gain access to the
bloodstream via intravenous catheter,
injection drug use, or a dental
infection for example (Holland et al.,
2016). These pathogens then adhere
to an area of abnormal cardiac valve
surface. The infected vegetation is
created by burying of the proliferating
organism within a protective matric of
serum molecules (Holland et al.,
2016). According to Holland et al.
(2016), “equivalent damage to the
valvular surface may result from a
variety of factors, including turbulent
blood flow related to primary valvular
damage from specific systemic
disease states (such as rheumatic
carditis), mechanical injury by
catheters or electrodes, or injury
arising from repeated injections of
solid particles in IDU. This endothelial
damage prompts

the formation of fibrin-platelet
deposits overlying interstitial edema”
(p. 3). Holland et al. (2016) elaborates,
“the development of IE requires the
simultaneous occurrence of several
independent factors: alteration of the
cardiac valve surface to produce a
suitable site for bacterial attachment
and colonization; bacteremia with an
organism capable of attaching to and
colonizing valve tissue; and creation of
the infected mass or ‘vegetation’ by
‘burying’ of the proliferating organism
within a protective matrix of serum
molecules (for example, fibrin) and
platelets” (p. 3). The bacterial
vegetation that develops on the
damaged cardiac valve surface can
detach and cause ischemic damage to
various areas or organs including the
brain, lungs, and extremities (Holland
et al., 2016)

Underlying
Pathophysiology
•

•

IE results in stimulation of both
humoral and cellular immunity, as
manifested by
hypergammaglobulinaemia,
splenomegaly and the presence of
macrophages in the peripheral blood
(Holland et al., 2016).
Several classes of circulating
antibodies are produced in response
to the continuous bacteremia that
typically characterizes IE. Opsonic
antibodies, agglutinating antibodies,
complement-fixing antibodies,
cryoglobulins and antibodies
directed against bacterial heat-shock
proteins and macroglobulin’s are
produced by the host in an effort to
control the ongoing infection
(Holland et al., 2016).

Implications For
Nursing Care
•

•

•

•

•

Figure 3. Mechanisms of Infective
Endocarditis (Holland et al., 2016)
•
Figure 4. Mechanisms of Infective Endocarditis
(Holland et al., 2016)
Figure 1. Infective Endocarditis (Liesman, Pritt, Maleszewski, &
Patel, 2018)

Significance of Pathophysiology
•
Determining the source and characteristics of the infection is vital in the
effectiveness of the treatment. Baddour et al. (2014) states, “at least 3 sets of
blood cultures obtained from different venipuncture sites should be obtained,
with the first and last samples drawn at least 1 hour apart (p. 1439). It is
important in this time that effective treatment of sepsis or other signs and
symptoms related to IE are being appropriately managed by the
interdisciplinary team.

Infective Endocarditis Antibiotic Treatments (Cobo Molinos, 2018)

Valve colonization due to mechanical
injury involves bacteria binding to
the coagulum and colonizing, the
adhered monocytes release tissue
factor and cytokines, as a results
more platelets are attract and
become activated causing the
vegetation to grow (Holland et al.,
2016)
Valve colonization as a consequence
of an inflammatory endothelial
lesion involves activated endothelial
cells that express integrins that
promote the local deposition of
fibronectin (Holland et al., 2016).
Bacteria are internalized and
endothelial cells release tissue factor
and cytokines, causing blood clotting
and promoting the extension of
inflammation and vegetation
formation (Holland et al., 2016)

The variability in clinical
presentation of IE and the
importance of early accurate
diagnosis require a diagnostic
strategy that is both sensitive for
disease detection and specific for
its exclusion across all forms of the
disease (Baddour et al., 2015)
The diagnosis of IE must be made
as soon as possible to initiate
appropriate empirical antibiotic
therapy and to identify patients at
high risk for complications who
may be best managed by early
surgery (Baddour et al., 2015)
Inpatients and outpatients with IE
should be educated by nursing to
help prevent and manage oral
diseases that predispose to
bacteremia and may therefore
contribute to the risk for recurrent
IE (Baddour et al., 2015).
Identify and manage the various
signs and symptoms associated
with IE including the unpredictable
nature of septic emboli (Holland et
al., 2016).
Educating those at increased risk
for developing IE including postoperative prosthetic heart valve
and other invasive surgeries.

Conclusion
IE is a serious condition that is on
the rise. According to Camou et al.
(2018), “the epidemiological profile
of IE in Western countries has
changed dramatically over the last
years because of the increased
scarcity of rheumatic fever, the
aging of the population, and the
emergence of new risk groups” (p.
4). Ensuring that the
interdisciplinary team is properly
educated on the management and
recognition of IE is vital to positive
outcomes of the patients. IE can
affect a diverse group of patients
ranging from intravenous drug user
to an elderly man after open heart
surgery. Exploring the
pathophysiology of IE helps
healthcare members in providing
the appropriate treatment plan.
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